RESPIRATORY SYNCYTIAL VIRUS (RSV)
Clinical trials for RESPIRATORY SYNCYTIAL VIRUS (RSV) explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUS (RSV) trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New vaccines against RSV and bird flu enter human testing
⭐️ VACCINE ⭐️ Not yet recruitingThis early-stage study tests the safety and immune response of experimental vaccines against RSV (a common respiratory virus) and the H5 bird flu strain. About 570 healthy adults aged 18 to 49 will receive different vaccine formulas and be monitored for side effects and antibody …
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE1 • Sponsor: Sanofi • Aim: ⭐️ VACCINE ⭐️
Last updated May 01, 2026 15:59 UTC
-
Pregnant women's RSV shot could shield thousands of brazilian babies from severe lung infections
⭐️ VACCINE ⭐️ Not yet recruitingThis study will check how well the RSVpreF vaccine works when given to pregnant women in Brazil. Researchers will follow 5000 infants up to 180 days old to see if the vaccine reduces hospitalizations and doctor visits for RSV-related breathing problems. The goal is to understand …
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Sponsor: Inova Medical • Aim: ⭐️ VACCINE ⭐️
Last updated May 01, 2026 15:57 UTC
-
New RSV vaccine trial aims to protect women from respiratory virus
⭐️ VACCINE ⭐️ Not yet recruitingThis early-stage study tests a new vaccine (MKK900) designed to protect against respiratory syncytial virus (RSV), a common cause of lung infections. About 120 healthy women aged 18-49 will receive either the new vaccine or an active control. Researchers will monitor for side eff…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE1 • Sponsor: MAXVAX Biotechnology Limited Liability Company • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 30, 2026 15:52 UTC
-
New pill could help babies breathe easier from RSV
Disease control Not yet recruitingThis study tests a new oral drug called zelicapavir in children aged 28 days to 36 months who have RSV infection. The drug aims to stop the virus from multiplying and help symptoms clear faster. About 150 children will participate, and the study compares the drug to a placebo to …
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE2 • Sponsor: Enanta Pharmaceuticals, Inc • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New RSV shot for infants enters safety trials
Prevention Not yet recruitingThis study tests a new injection called SIBP-A16 in 36 premature and full-term infants under 1 year old. The goal is to see if it is safe and how the body processes it, with the aim of preventing severe RSV infection. Babies receive either the study drug, a placebo, or an active …
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Institute Of Biological Products • Aim: Prevention
Last updated Apr 30, 2026 15:50 UTC